Company intelligence
Terray Therapeutics
Everything small molecule drug discovery should be.
About Terray Therapeutics
Terray is a biotechnology company with the technology, data, and mindset to radically change the way we discover and develop small molecule therapeutics. We explore molecules and targets broadly and deeply with a sophisticated integration of ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology. Everything the company does is grounded in an iterative approach, producing massive amounts of precise, purpose-built data that gets increasingly valuable with each cycle of design and experimentation. The company’s platform uniquely blends experimentation and computation to improve the cost, speed, and success rate of small molecule drug discovery and development.
Verified activity
Signals from Terray Therapeutics
3 published signals
People
Terray Therapeutics hosted master's students from the Master of Molecular Science and Software Engineering (MSSE), UC Berkeley program for a capstone internship.
Reported by Terray Therapeutics
Presence & Recognition
Terray Therapeutics will present at the Morgan Stanley 24th Annual Global Healthcare Conference from September 14th to 16th.
Reported by Terray Therapeutics
Presence & Recognition
Terray Therapeutics will present at the Goldman Sachs Life Sciences Symposium on September 15th.
Reported by Terray Therapeutics